This invention relates to a method for modulating, inhibiting or decreasing or preventing beta cell degeneration, loss of beta cell function, beta cell dysfunction, andor death of beta cells, such as necrosis or apoptosis of beta cells in a subject comprising administering a GLP-1 agonist to said subject. Each of the consumer electronic devices is assigned a unique address, such that each of the consumer electronics devices is individually addressable via the telephone line. The fluid channel has a passageway that is straight and has a constant slope with respect to the head surface. The control system utilizes the data gathered to identify a risk of an adverse event occurring to a patient supported on the patient support apparatus. In addition the patient admittance may be compared with admittance during normal breathing to avoid having to characterize the airway. The amount of cream deposited on the gauze is regulated by applying pressure to various parts of the device.